Sign in
Taking peopleNo phase

Sorbact dressings and bacteria and fungi from hard-to-heal wounds

Explores whether coated dressings bind germs from hard-to-heal wounds in adults.

Key facts

Who runs it
ABIGO Medical AB
Where
Sweden1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Clinical Investigation of Sorbact® Dressings
Status
Recruiting
People taking part
30 people, planned
Started
5 Apr 2025
Expected to end
Dec 2026
Type of study
Interventional, 3 groups
Treatments tested
  • Sorbact® Compress
  • Sorbact® Gel Dressing
  • Sorbact® Ribbon Gauze
Record updated
14 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a hard-to-heal wound who are about to start using a Sorbact® dressing. It studies how germs and fungi from the wound stick to the dressing.

Age
18 years or older.
Sex
All sexes can join.
Disease stage
A hard-to-heal wound present for 6 weeks or more, with no clear shrinking of the wound in the last 4 weeks. This can be a diabetic foot ulcer, leg ulcer or pressure ulcer.
Earlier treatment
You must be due to start Sorbact® Compress, Sorbact® Gel Dressing or Sorbact® Ribbon Gauze. You cannot join if you used a germ-killing product (such as silver or iodine dressings or gels) or any Sorbact® dressing in the last two weeks.

Main reasons for not taking part

  • Taking part in another clinical study.
  • Known allergy or sensitivity to any part of the dressing used.
  • Use of germ-killing dressings or gels in the last two weeks.
  • Use of a Sorbact® dressing in the last two weeks.
  • Any other condition that the study doctor thinks makes the study steps unsafe or unsuitable for you.

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Able to read and understand the Subject Information and Informed Consent Form and provide meaningful informed consent
  • Due to start using one of the following dressings: Sorbact® Compress, Sorbact® Gel Dressing and Sorbact® Ribbon Gauze
  • Age ≥18 years
  • Presence of hard-to-heal wound for ≥6 weeks with no significant wound area reduction for the last 4 weeks confirmed by investigator/study nurse

Who cannot take part

  • Known allergy or sensitivity to any components of the allocated investigational device
  • Subjects with any other condition that as judged by the investigator may make investigation procedures inappropriate
  • Participating in another clinical investigation
  • Use of antimicrobial agent (e.g., silver- or iodine-containing dressings, or gels) during the last wo weeks
  • Use of a dressing from the Sorbact® range during the last two weeks

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main purpose of this exploratory clinical investigation is to study the binding of bacteria and fungi from hard-to-heal wounds to the DACC-coated dressings.

The 3 groups in the trial

  • Sorbact® CompressOther group

    Patients already assigned to start treatment with Sorbact® Compress as it is judged by the investigator to be the most suitable for their wounds

  • Sorbact® Gel DressingOther group

    Patients already assigned to start treatment with Sorbact® Gel Dressing as it is judged by the investigator to be the most suitable for their wounds

  • Sorbact® Ribbon GauzeOther group

    Patients already assigned to start treatment with Sorbact® Ribbon Gauze as it is judged by the investigator to be the most suitable for their wounds

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Open, Single-centre, Clinical Investigation to Explore the Binding of Bacteria and Fungi to Dialkylcarbamoyl Chloride (DACC)-Coated Dressings From Hard-to-heal Wounds
Plain-language title
Sorbact dressings and bacteria and fungi from hard-to-heal woundsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
14 September 2026